Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Oncternal Therapeutics, Inc. | CTO/CSO | Common Stock | 44K | $21.8K | $0.50 | Jan 3, 2024 | Direct |
Oncternal Therapeutics, Inc. | CTO/CSO | Stock Option | 17.7K | Feb 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ONCT | Oncternal Therapeutics, Inc. | Feb 14, 2024 | 1 | $0 | 4 | Feb 15, 2024 | CTO/CSO |
ONCT | Oncternal Therapeutics, Inc. | Jan 3, 2024 | 1 | -$5.87K | 4 | Jan 5, 2024 | Chief Technical Officer |
ONCT | Oncternal Therapeutics, Inc. | Oct 2, 2023 | 14 | $0 | 4 | Oct 4, 2023 | Chief Technical Officer |
ONCT | Oncternal Therapeutics, Inc. | Jul 3, 2023 | 1 | -$3.92K | 4 | Jul 5, 2023 | Chief Technology Officer |
ONCT | Oncternal Therapeutics, Inc. | Feb 21, 2023 | 1 | $0 | 4 | Feb 23, 2023 | Chief Technology Officer |
ONCT | Oncternal Therapeutics, Inc. | Jan 3, 2023 | 1 | -$6.36K | 4 | Jan 5, 2023 | Chief Technology Officer |
ONCT | Oncternal Therapeutics, Inc. | Jul 28, 2022 | 2 | $0 | 4 | Aug 1, 2022 | Chief Technology Officer |
ONCT | Oncternal Therapeutics, Inc. | Jan 20, 2022 | 1 | $0 | 4 | Jan 24, 2022 | Chief Technology Officer |
ONCT | Oncternal Therapeutics, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Chief Technology Officer |
ONCT | Oncternal Therapeutics, Inc. | May 25, 2021 | 0 | $0 | 3 | May 27, 2021 | Chief Technology Officer |